Cancer Outcomes

Our Cancer Program has impressive diagnostic and treatment results when compared to regional, state, and national averages, as measured by the American College of Surgeons Commission on Cancer. The American College of Surgeons Commission on Cancer evaluates Community Hospital’s Cancer Program every three years.

Our Comprehensive Cancer Center

Radiation therapy for breast cancer

Radiation therapy after partial mastectomy or lumpectomy dramatically decreases the risk of recurrence.

Performance rate Number of cases
Community Hospital of the Monterey Peninsula 93.9% 49
California — all cancer programs 88% 4,634
Pacific region* — all cancer programs 89.5% 7,193
Program type - all comprehensive cancer centers 91.6% 24,672
All Commission on Cancer-approved programs in U.S. 91.7% 56,999

Hormone therapy for breast cancer

For a specific type of breast cancer, hormone therapy after surgery, such as use of the drug Tamoxifen, clearly decreases the risk of recurrence.

Performance rate Number of cases
Community Hospital of the Monterey Peninsula 100% 52
California — all cancer programs 88% 6,496
Pacific region* — all cancer programs 94.5% 10,008
Program type - all comprehensive cancer centers 92% 33,844
All Commission on Cancer-approved programs in U.S. 92.1 % 76,141

Chemotherapy for colon cancer

Chemotherapy administered within 4 months of diagnosis of stage III (lymph node positive) colon cancer, decreases the risk of recurrence.

Performance rate Number of cases
Community Hospital of the Monterey Peninsula 90.9% 11
California — all cancer programs 85.3% 714
Pacific region* — all cancer programs 87.5 % 1,085
Program type - all comprehensive cancer centers 88.4% 4,346
All Commission on Cancer-approved programs in U.S. 88.2 % 9,885

Chemotherapy for lung cancer

For a specific type of lung cancer, chemotherapy is administered within 4 months prior to or 6 months after lung cancer surgery, decreases the risk of recurrence.

Performance rate Number of cases
Community Hospital of the Monterey Peninsula 100% 3
California — all cancer programs 88.6% 264
Pacific region* — all cancer programs 90.6 % 426
Program type - all comprehensive cancer centers 90% 1,644
All Commission on Cancer-approved programs in U.S. 90.8% 4,243

*Alaska, California, Hawaii, Oregon, and Washington

Read more about the Commission on Cancer’s performance measures.